BioVie Inc.
BIVI
$7.14
-$0.43-5.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 60.80% | -71.30% | 15.97% | 38.76% | 3.97% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -100.00% | -74.74% | -42.42% | -97.93% | 2,502.28% |
| Total Other Non-Cash Items | -1.07% | 21.53% | -66.30% | 302.40% | 38.62% |
| Change in Net Operating Assets | 135.11% | -3,040.65% | 91.65% | -191.05% | -55.42% |
| Cash from Operations | 85.40% | -139.83% | 10.66% | 31.53% | 0.99% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -34.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | 622.27% | -- | -100.00% | 148.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 5,482.69% | 90.36% | -115.65% | 224.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -128.61% | 214.70% | 41.28% | -164.27% | 1,124.66% |